Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Directorate Change

9 May 2013 13:20

RNS Number : 3604E
Plant Health Care PLC
09 May 2013
 



 

 

09 May 2013

 

PLANT HEALTH CARE PLC

 

("Plant Health Care" or "the Company")

 

Directorate Change

 

Plant Health Care appoints Michael Higgins as Senior Independent Director

 

Plant Health Care (AIM / CISX: PHC.L), a leading provider of novel patent protected biological products to the global agriculture markets confirms that, further to the announcement of 26 March 2013, Mr Michael Higgins has today joined the Company as Senior Independent Director and Chair of the Audit Committee.

 

Mr Higgins, aged 56, is currently non-executive Chairman of AIM quoted Ebiquity PLC and Deputy Chairman of the Quoted Companies Alliance. Michael also works with, and invests in, a number of early stage businesses. Michael was a Senior Adviser at KPMG following ten years as a Partner. Prior to KPMG he was a Director at Charterhouse Bank, worked at Saudi International Bank and qualified as an accountant with Price Waterhouse (now PricewaterhouseCoopers).

 

Dr Christopher Richards, Chairman of Plant Health Care, commented: "I am very pleased to welcome Michael onto the Board. He brings a wealth of additional experience from which Plant Health Care will benefit. His long-standing involvement with AIM and growth companies will prove invaluable."

 

Save for the information disclosed above there is no other information to be disclosed under Rule 17 or Schedule Two, paragraph (g) of the AIM Rules for Companies in relation to Mr Michael James Higgins' appointment as a Director of the Company other than as follows:

 

Michael James Higgins:

 

Current Directorships

Past Directorships

Ebiquity PLC (appointed 1 May 2006)

Bronze Health Community Interest Company 1

The Quoted Companies Alliance (appointed 7 October 2008)

Brown Health Community Interest Company 1

Charcoal Health Community Interest Company 2

Carnation Health Community Interest Company 1

Cerise Health Community Interest Company 1

Chestnut Health Community Interest Company 1

Cobalt Health Community Interest Company 1

Copper Health Community Interest Company 1

Coral Health Community Interest Company 1

Crimson Health Community Interest Company 1

Ecru Health Community Interest Company 1

Fuchsia Health Community Interest Company 1

Grey Health Community Interest Company 1

Holly Health Community Interest Company 1

Indigo Health Community Interest Company 1

Ivory Health Community Interest Company 1

Jade Health Community Interest Company 1

Lavender Health Community Interest Company 1

Lemon Health Community Interest Company 1

Lime Health Community Interest Company 1

Magenta Health Community Interest Company 1

Maroon Health Community Interest Company 1

Olive Health Community Interest Company 1

Orchid Health Community Interest Company 1

Pearl Health Community Interest Company 1

Peoples Health Trust (4 February 2008 until 21 April 2009)

Pine Health Community Interest Company 1

Purple Health Community Interest Company 1

Sienna Health Community Interest Company 1

Teal Health Community Interest Company 1

Violet Health Community Interest Company 1

Yellow Health Community Interest Company 1

 

1 Director from incorporation on 14 May 2008 until dissolution on 26 October 2010

2 Currently in process of solvent liquidation

 

~ Ends ~

 

About Plant Health Care plc: Plant Health Care plc ("Plant Health Care") is a leading provider of novel patent protected biological products to the global agriculture markets. The Company's ordinary shares have been quoted on the AIM Market of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") since February 2010 (ticker symbol/mnemonic: PHC).

 

Further information is available at: www.planthealthcare.comor please contact:

Plant Health Care plc

Dr Chris Richards, Chairman

Tel: +44 (0) 20 7250 1446

Paul Schmidt, Chief Executive Officer

Tel: +1-412-826-5488

Stephen Weaver, Finance Director

Tel: +1-412-826-5488

Nomura Code Securities

Tel: +44 (0) 20 7776 1200

Clare Terlouw / Chris Golden

Powerscourt

Tel: +44 (0) 20 7250 1446

Paul Durman / Nick Dibden / Sophie Moate

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALKLFBXEFFBBD
Date   Source Headline
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.